e-Therapeutics plc Notification of Full Year Results Date (3365H)
March 12 2018 - 2:00AM
UK Regulatory
TIDMETX
RNS Number : 3365H
e-Therapeutics plc
12 March 2018
e-Therapeutics plc
("e-Therapeutics" or the "Company")
Notification of Full Year Results Date
Oxford, UK - 12 March 2018 - e-Therapeutics plc (AIM: ETX), a
company using Network-Driven Drug Discovery (NDD) to create new and
better drugs, will announce its full year results for the year
ended 31 January 2018 on Tuesday, 27 March 2018.
-Ends-
For more information, please contact:
e-Therapeutics plc Tel: +44 (0)1993
Raymond Barlow, CEO 883 125
Steve Medlicott, Finance www.etherapeutics.co.uk
Director
Numis Securities Limited Tel: +44 (0) 207
Michael Meade / Freddie Barnfield 260 1000
(Corporate Finance) www.numis.com
James Black (Corporate Broking)
Instinctif Partners Tel: +44 (0) 207
Melanie Toyne Sewell / Alex 457 2020
Shaw / Deborah Bell Email: e-therapeutics@instinctif.com
About e-Therapeutics plc
e-Therapeutics is an Oxford-based company with a unique and
powerful computer-based drug discovery platform and a specialised
approach to network biology.
Its novel methodology and Discovery Engine allow the Company to
discover new and better drugs in a more efficient and effective
way.
For more information about the Company, please visit
www.etherapeutics.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORBXGDXCSBBGIB
(END) Dow Jones Newswires
March 12, 2018 03:00 ET (07:00 GMT)
E-therapeutics (LSE:ETX)
Historical Stock Chart
From Apr 2024 to May 2024
E-therapeutics (LSE:ETX)
Historical Stock Chart
From May 2023 to May 2024